Company Filing History:
Years Active: 2009-2015
Title: Judithann M Lee: Innovator in Antigen Binding Proteins and Wound Healing
Introduction
Judithann M Lee is a prominent inventor based in King of Prussia, PA (US). She has made significant contributions to the fields of biotechnology and medicine, particularly through her innovative patents. With a total of 2 patents, her work focuses on critical health issues, including cancer treatment and wound healing.
Latest Patents
One of Judithann's latest patents involves antigen binding proteins. This patent discloses proteins, such as antibodies, that specifically bind to HER3. It also includes polynucleotides encoding these proteins, pharmaceutical compositions containing them, and methods of manufacture. The application of these proteins is particularly relevant in treating or preventing diseases associated with various cancers, including breast, ovarian, prostate, bladder, pancreatic, gastric, melanoma, and others that overexpress HER3.
Another significant patent relates to methods of healing wounds by administering human IL-18. This invention focuses on the use of human IL-18, also known as interferon-γ-inducing factor (IGIF), for treating skin wounds, surgical wounds, leg ulcers, diabetic ulcers, gastrointestinal mucositis, oral mucositis, and lung injury.
Career Highlights
Judithann has worked with notable companies in the pharmaceutical and biotechnology sectors. She has been associated with SmithKline Beecham Corporation and GlaxoSmithKline Intellectual Property Development Limited. Her experience in these organizations has contributed to her expertise in developing innovative solutions for health-related challenges.
Collaborations
Throughout her career, Judithann has collaborated with several professionals in her field. Some of her notable coworkers include Kimberly A Dede and Neil James Clarke. These collaborations have likely enriched her work and expanded the impact of her inventions.
Conclusion
Judithann M Lee is a remarkable inventor whose work in antigen binding proteins and wound healing has the potential to significantly improve patient outcomes. Her contributions to the field of biotechnology exemplify the importance of innovation in addressing critical health issues.